These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33864649)

  • 1. Nontargeted detection of designer androgens: Underestimated role of in vitro bioassays.
    Lund RA; Cooper ER; Wang H; Ashley Z; Cawley AT; Heather AK
    Drug Test Anal; 2021 May; 13(5):894-902. PubMed ID: 33864649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-free bioassay for the detection of androgens.
    Cooper ER; Hughes G; Kauff A; Sutherland E; Ashley Z; Heather AK
    Drug Test Anal; 2021 May; 13(5):903-915. PubMed ID: 33709622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile.
    Piper T; Heimbach S; Adamczewski M; Thevis M
    Drug Test Anal; 2021 May; 13(5):916-928. PubMed ID: 33283964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
    Clarke A; Scarth J; Teale P; Pearce C; Hillyer L
    Drug Test Anal; 2011 Jan; 3(1):74-87. PubMed ID: 21322180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro androgen bioassays as a detection method for designer androgens.
    Cooper ER; McGrath KC; Heather AK
    Sensors (Basel); 2013 Feb; 13(2):2148-63. PubMed ID: 23389345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs.
    Bailey K; Yazdi T; Masharani U; Tyrrell B; Butch A; Schaufele F
    PLoS One; 2016; 11(3):e0151860. PubMed ID: 26998755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.
    Cadwallader AB; Lim CS; Rollins DE; Botrè F
    J Anal Toxicol; 2011 Nov; 35(9):594-607. PubMed ID: 22080898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer androgens in sport: when too much is never enough.
    Handelsman DJ
    Sci STKE; 2004 Jul; 2004(244):pe41. PubMed ID: 15292520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
    McKinney AR
    Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen- and estrogen-receptor mediated activities of 4-hydroxytestosterone, 4-hydroxyandrostenedione and their human metabolites in yeast based assays.
    Keiler AM; Zierau O; Wolf S; Diel P; Schänzer W; Vollmer G; Machalz D; Wolber G; Parr MK
    Toxicol Lett; 2018 Aug; 292():39-45. PubMed ID: 29702199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SERMs and SARMs: detection of their activities with yeast based bioassays.
    Bovee TF; Thevis M; Hamers AR; Peijnenburg AA; Nielen MW; Schoonen WG
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):85-92. PubMed ID: 19883760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport.
    Bohlin KP; Pohanka A; Andersson A; Villén T; Ekström L
    Drug Test Anal; 2024 Aug; 16(8):827-834. PubMed ID: 37986708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis.
    Pozo OJ; De Brabanter N; Fabregat A; Segura J; Ventura R; Van Eenoo P; Deventer K
    Bioanalysis; 2013 Nov; 5(21):2661-77. PubMed ID: 24180506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrogestrinone analysis and designer steroids revisited.
    Pereira HM; Padilha MC; Neto FR
    Bioanalysis; 2009 Nov; 1(8):1475-89. PubMed ID: 21083096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.
    Akram ON; Bursill C; Desai R; Heather AK; Kazlauskas R; Handelsman DJ; Lambert G
    Anal Chem; 2011 Mar; 83(6):2065-74. PubMed ID: 21329390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen abuse in sports.
    Handelsman DJ; Heather A
    Asian J Androl; 2008 May; 10(3):403-15. PubMed ID: 18385902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.